Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Stargardt's disease/fundus flavimaculatus: Psychophysical and electrophysiologic results

  • 77 Accesses

  • 18 Citations


Retinal functions were analyzed psychophysically and electrophysiologically in 73 patients (146 eyes) with Stargardt's disease/fundus flavimaculatus. Patients were classified into types 1, 2, 3, and 4; patients with type 3 were subdivided into 3E and 3L (early and late onset of initial symptoms). Most had visual acuity (VA) of 20/200 or greater at initial testing. VA declined 0.25 octave/year during follow-up (mean, 6.1 years). Four of 16 patients (25%) older than 40 years had VA of 20/200 or less in the stronger eye. Psychophysical tests (flicker profile, central scotoma, dark adaptation) showed variable degrees of abnormalities. Electrophysiological tests showed significant photopic b-wave amplitude decreases, particularly in type 3E (42.2% of normal). The electro-oculogram light peak/dark trough ratio was abnormal in 60 of 132 eyes (45.5%), especially in type 3E (25 of 34 eyes, 73.5%). Visual prognosis and overall visual function varied depending upon disease type, location of retinal lesions, and age of onset. In Type 3E, overall retinal function was poorest and accompanied by the most severe decline of central vision and function in the surrounding macula.

This is a preview of subscription content, log in to check access.


  1. 1.

    Aaberg TM (1986) Stargardt's disease and fundus flavimaculatus. Evaluation of morphologic progression and intrafamilial co-existence. Trans Am Ophthalmol Soc 84:453–487

  2. 2.

    Anmarkrud N (1979) Fundus fluorescein angiography in fundus flavimaculatus and Stargardt's disease. Acta Ophthalmol 57:172–182

  3. 3.

    Arden GB, Barrada A, Kelsey JH (1962) New clinical test of retinal function based upon the standing potential of the eye. Br J Ophthalmol 46:449–467

  4. 4.

    Carr RE (1965) Fundus flavimaculatus. Arch Ophthalmol 74:163–168

  5. 5.

    Cibis GW, Morey M, Harris DJ (1980) Dominantly inherited macular dystrophy with flecks (Stargardt). Arch Ophthalmol 98:1785–1789

  6. 6.

    Deutman AF (1971) The hereditary dystrophies of the posterior pole of the eye. Thomas, Springfield

  7. 7.

    Doka DS, Fishman GA, Anderson RJ (1982) Refractive errors in patients with fundus flavimaculatus. Br J Ophthalmol 66:227–229

  8. 8.

    Eagle RC, Lucier AC, Bernardino VB, Yanoff M (1980) Retinal pigment epithelial abnormalities in fundus flavimaculatus. Ophthalmology 87:1189–1200

  9. 9.

    Fish G, Grey R, Sehmi KS, Bird AC (1981) The dark choroid in posterior retinal dystrophies. Br J Ophthalmol 65:359–363

  10. 10.

    Fishman GA (1976) Fundus flavimaculatus. A clinical classification. Arch Ophthalmol 94:2061–2067

  11. 11.

    Fishman GA, Farber M, Patel BS, Derlacki DJ (1987) Visual acuity loss in patients with Stargardt's macular dystrophy. Ophthalmology 94:809–814

  12. 12.

    Fishman GA, Farbman JS, Alexander KR (1991) Delayed rod dark adaptation in patients with Stargardt's disease. Ophthalmology 98:957–962

  13. 13.

    Franceschetti A, Franqois J (1965) Fundus flavimaculatus. Arch D'Ophtalmol (Paris) 25:505–530

  14. 14.

    Gelisken O, De Laey JJ (1985) A clinical review of Stargardt's disease and/or fundus flavimaculatus with follow-up. Int Ophthalmol 82:25–236

  15. 15.

    Hadden OB, Gass JDM (1976) Fundus flavimaculatus and Stargardt's disease. Am J Ophthalmol 82:527–539

  16. 16.

    Hirose T, Katsumi O, Pruett RC, Sakaue H, Mehta M (1991) Retinal function in birdshot retinopathy. Acta Ophthalmol 69:327–337

  17. 17.

    Klien BA, Krill AE (1967) Fundus flavimaculatus. Clinical, functional and histopathologic observations. Am J Ophthalmol 64:3–23

  18. 18.

    Krill AE, Klien BA (1965) Flecked retina syndrome. Arch Ophthalmol 74: 496–508

  19. 19.

    Lachapelle P, Little JM, Sylvie M (1990) The electroretinogram in Stargardt's disease and fundus flavimaculatus. Doc Ophthalmol 73: 395–404

  20. 20.

    Lopez PF, Maumenee IH, Cruz Z, Green WR (1990) Autosomal-dominant fundus flavimaculatus. Ophthalmology 97:798–809

  21. 21.

    McMahon TT, Maino JH, Farber MD (1985) Treatment of low vision in fundus flavimaculatus. Arch Ophthalmol 103:1325–1328

  22. 22.

    Merin S, Landau J (1970) Abnormal findings in relatives of patients with juvenile hereditary macular degeneration (Stargardt's disease). Ophthalmologica 16:1–10

  23. 23.

    Moloney JBM, Mooney DJ, O'Connor MA (1983) Retinal function in Stargardt's disease and fundus flavimaculatus. Am J Ophthalmol 96:57–65

  24. 24.

    Newell FW, Krill AE, Farkas TG (1972) Drusen and fundus flavimaculatus. Clinical, functional and histological characteristics. Trans Am Acad Ophthalmol Otolaryngol 76:88–100

  25. 25.

    Noble KG, Carr RE (1971) Stargardt's disease and fundus flavimaculatus. Arch Ophthalmol 97:1281–1285

  26. 26.

    Stargardt K (1909) Über familiäre, progressive Degeneration in der Maculagegend des Auges. Graefes Arch Klin Ophthalmol 71:534–550

  27. 27.

    Vail D, Shoch D (1965) Hereditary degeneration of the macula. II. Follow-up report and histopathologic study. Trans Am Ophthalmol Soc 63:51–61

  28. 28.

    Wolf E, Gaeta AM, Geer SE (1968) Critical flicker frequencies in flicker perimetry. Arch Ophthalmol 80: 347–351

Download references

Author information

Correspondence to Ryuzo Itabashi.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Itabashi, R., Katsumi, O., Mehta, M.C. et al. Stargardt's disease/fundus flavimaculatus: Psychophysical and electrophysiologic results. Graefe's Arch Clin Exp Ophthalmol 231, 555–562 (1993). https://doi.org/10.1007/BF00936518

Download citation


  • Visual Acuity
  • Visual Function
  • Disease Type
  • Dark Adaptation
  • Scotoma